Lumithera Inc. has completed the acquisition of Diopsys Inc. to expand its footprint of ocular disease care. Under the terms of the agreement, Pine Brook, N.J.-based Diopsys is now a wholly owned subsidiary of Poulsbo, Wash.-based Lumithera, with its electroretinography technology adding to Lumithera’s photobiomodulation (PBM) Valeda light delivery system for dry age-related macular degeneration (AMD) treatment.